RE: General13 Feb 2019 17:05
You say we’d need more funding notrac, when you think about it all these big pharma companies will be waiting on positive phase 3 data, we’ll have data by the end of the year and they’re even ahead of schedule as said in the presentation. I believe with positive data then, the likelyhood of a buyout would be pretty high.
And at the moment why wouldn’t Lombard take some profit, I mean to me it makes sense after them buying in heavy at 7p. The interesting thing has been the volume recently ever since the start of the year, Lombard have been ofloading shares but to me another institution must’ve been buying in. The increase in volume can’t just be from PI’s.